PF-07985631

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-07985631, covering 2026-03-19 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults [Phase 1]

See pricing